Biofrontera Balance Sheet Health

Financial Health criteria checks 6/6

Biofrontera has a total shareholder equity of $5.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $18.5M and $13.0M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$2.88m
EquityUS$5.53m
Total liabilitiesUS$12.99m
Total assetsUS$18.52m

Recent financial health updates

Can Biofrontera (NASDAQ:BFRI) Afford To Invest In Growth?

Oct 18
Can Biofrontera (NASDAQ:BFRI) Afford To Invest In Growth?

Recent updates

Biofrontera Inc.'s (NASDAQ:BFRI) Shares Leap 25% Yet They're Still Not Telling The Full Story

Sep 28
Biofrontera Inc.'s (NASDAQ:BFRI) Shares Leap 25% Yet They're Still Not Telling The Full Story

Further Upside For Biofrontera Inc. (NASDAQ:BFRI) Shares Could Introduce Price Risks After 40% Bounce

Aug 09
Further Upside For Biofrontera Inc. (NASDAQ:BFRI) Shares Could Introduce Price Risks After 40% Bounce

Take Care Before Jumping Onto Biofrontera Inc. (NASDAQ:BFRI) Even Though It's 29% Cheaper

May 24
Take Care Before Jumping Onto Biofrontera Inc. (NASDAQ:BFRI) Even Though It's 29% Cheaper

Biofrontera Inc. (NASDAQ:BFRI) Not Doing Enough For Some Investors As Its Shares Slump 28%

Dec 30
Biofrontera Inc. (NASDAQ:BFRI) Not Doing Enough For Some Investors As Its Shares Slump 28%

The Market Doesn't Like What It Sees From Biofrontera Inc.'s (NASDAQ:BFRI) Revenues Yet As Shares Tumble 43%

Nov 13
The Market Doesn't Like What It Sees From Biofrontera Inc.'s (NASDAQ:BFRI) Revenues Yet As Shares Tumble 43%

Can Biofrontera (NASDAQ:BFRI) Afford To Invest In Growth?

Oct 18
Can Biofrontera (NASDAQ:BFRI) Afford To Invest In Growth?

Biofrontera announces preliminary Q3 product revenue, stock falls ~7% after hours

Oct 05

Biofrontera gets notice of allowance for U.S. patent covering a nanoemulsion formulation

Sep 06

Financial Position Analysis

Short Term Liabilities: BFRI's short term assets ($16.9M) exceed its short term liabilities ($11.0M).

Long Term Liabilities: BFRI's short term assets ($16.9M) exceed its long term liabilities ($2.0M).


Debt to Equity History and Analysis

Debt Level: BFRI is debt free.

Reducing Debt: BFRI had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BFRI has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: BFRI is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies